subject area of
- A cross-neutralizing antibody between HIV-1 and influenza virus Academic Article
- A highly conserved neutralizing epitope on group 2 influenza a viruses Academic Article
- A structural explanation for the low effectiveness of the seasonal influenza H3N2 vaccine Academic Article
- Consensus M2e peptide conjugated to gold nanoparticles confers protection against H1N1, H3N2 and H5N1 influenza A viruses Academic Article
- Cross-neutralization of influenza a viruses mediated by a single antibody loop Academic Article
- Design and synthesis of 1,2,3-triazole-containing N-acyl zanamivir analogs as potent neuraminidase inhibitors Academic Article
- Different genetic barriers for resistance to HA stem antibodies in influenza H3 and H1 viruses Academic Article
- Enhanced human-type receptor binding by ferret-transmissible H5N1 with a K193T mutation Academic Article
- Heterosubtypic antibody recognition of the influenza virus hemagglutinin receptor binding site enhanced by avidity Academic Article
- In vitro pharmacological selectivity profile of oseltamivir prodrug (tamiflu (r)) and active metabolite Academic Article
- Influenza A virus neuraminidase limits viral superinfection Academic Article
- Influenza a virus matrix protein 1-specific human cd8(+) t-cell response induced in trivalent inactivated vaccine recipients Academic Article
- Influenza virus neuraminidases with reduced enzymatic activity that avidly bind sialic acid receptors Academic Article
- Major antigenic site B of human influenza H3N2 viruses has an evolving local fitness landscape Academic Article
- Receptor mimicry by antibody F045-092 facilitates universal binding to the H3 subtype of influenza virus Academic Article
- Receptor specificity of influenza a h3n2 viruses isolated in mammalian cells and embryonated chicken eggs Academic Article
- Synthesis of acylguanidine zanamivir derivatives as neuraminidase inhibitors and the evaluation of their bio-activities Academic Article